Helicobacter-negative gastritis: A distinct entity unrelated to Helicobacter pylori infection

Alimentary Pharmacology and Therapeutics

Volumn 41, Issue 2, 2015, Pages 218-226

  Genta, R M ^a,b   Sonnenberg, A ^c  

^a MIRACA LIFE SCIENCES   (United States)

^b UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

^c OREGON HEALTH AND SCIENCE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGE DISTRIBUTION; ARTICLE; COMPARATIVE STUDY; CONTROLLED STUDY; DISEASE ASSOCIATION; FEMALE; GASTRITIS; GEOGRAPHIC DISTRIBUTION; HELICOBACTER INFECTION; HELICOBACTER NEGATIVE GASTRITIS; HUMAN; HUMAN TISSUE; INFLAMMATORY BOWEL DISEASE; INTESTINE METAPLASIA; MAJOR CLINICAL STUDY; MALE; SEX DIFFERENCE; STOMACH BIOPSY; AGE; BIOPSY; CLASSIFICATION; HELICOBACTER INFECTIONS; HELICOBACTER PYLORI; ISOLATION AND PURIFICATION; MEDICAL GEOGRAPHY; METAPLASIA; MICROBIOLOGY; MIDDLE AGED; PATHOLOGY; PREVALENCE; STOMACH MUCOSA; UNITED STATES;

ADULT; AGE DISTRIBUTION; AGE FACTORS; BIOPSY; FEMALE; GASTRIC MUCOSA; GASTRITIS; GEOGRAPHY, MEDICAL; HELICOBACTER INFECTIONS; HELICOBACTER PYLORI; HUMANS; MALE; METAPLASIA; MIDDLE AGED; PREVALENCE; SEX FACTORS; UNITED STATES;

EID: 84918559607     PISSN: 02692813     EISSN: 13652036     Source Type: Journal    
DOI: 10.1111/apt.13007     Document Type: Article

References (29)

1. Marshall BJ, Warren JR,. Unidentified curved bacilli in the stomach of patients with gastritis and peptic ulceration. Lancet 1984; 1: 1311-5.
2. Parsonnet J, Friedman GD, Vandersteen DP, et al,. Helicobacter pylori infection and the risk of gastric carcinoma. N Engl J Med 1991; 325: 1127-31.
3. Isaacson PG,. Extranodal lymphomas: the MALT concept. Verh Dtsch Ges Pathol 1992; 76: 14-23.
4. Talley NJ, Li Z,. Helicobacter pylori: testing and treatment. Expert Rev Gastroenterol Hepatol 2007; 1: 71-9.
5. Dixon MF, Genta RM, Yardley JH, Correa P,. Classification and grading of gastritis. The updated Sydney System. International Workshop on the Histopathology of Gastritis, Houston 1994. Am J Surg Pathol 1996; 20: 1161-81.
6. Zaitoun AM,. Use of Romanowsky type (Diff-3) stain for detecting Helicobacter pylori in smears and tissue sections. J Clin Pathol 1992; 45: 448-9.
7. Genta RM, Robason GO, Graham DY,. Simultaneous visualization of Helicobacter pylori and gastric morphology: a new stain. Hum Pathol 1994; 25: 221-6.
8. Vartanian RK, Leung JK, Davis JE, et al,. A novel Alcian yellow-toluidine blue (Leung) stain for Helicobacter species: comparison with standard stains, a cost-effectiveness analysis, and supplemental utilities. Mod Pathol 1998; 11: 72-8.
9. Genta RM, Lash RH,. Helicobacter pylori-negative gastritis: seek, yet ye shall not always find. Am J Surg Pathol 2010; 34: e25-34.
10. Laine L, Weinstein WM,. Subepithelial hemorrhages and erosions of human stomach. Dig Dis Sci 1988; 33: 490-503.
11. Stolte M, Panayiotou S, Schmitz J,. Can NSAID/ASA-induced erosions of the gastric mucosa be identified at histology? Pathol Res Pract 1999; 195: 137-42.
12. Laine L, Weinstein WM,. Histology of alcoholic hemorrhagic "gastritis": a prospective evaluation. Gastroenterology 1988; 94: 1254-62.
13. Pusztaszeri MP, Genta RM, Cryer BL,. Drug-induced injury in the gastrointestinal tract: clinical and pathologic considerations. Nat Clin Pract Gastroenterol Hepatol 2007; 4: 442-53.
14. Neumann WL, Coss E, Rugge M, Genta RM,. Autoimmune atrophic gastritis-pathogenesis, pathology and management. Nat Rev Gastroenterol Hepatol 2013; 10: 529-41.
15. Oberhuber G, Puspok A, Oesterreicher C, et al,. Focally enhanced gastritis: a frequent type of gastritis in patients with Crohn's disease. Gastroenterology 1997; 112: 698-706.
16. Genta RM, Sonnenberg A,. Non-Helicobacter pylori gastritis is common among paediatric patients with inflammatory bowel disease. Aliment Pharmacol Ther 2012; 35: 1310-6.
17. Sonnenberg A, Genta RM,. Low prevalence of Helicobacter pylori infection among patients with inflammatory bowel disease. Aliment Pharmacol Ther 2012; 35: 469-76.
18. Graham DY, Opekun AR, Yamaoka Y, et al,. Early events in proton pump inhibitor-associated exacerbation of corpus gastritis. Aliment Pharmacol Ther 2003; 17: 193-200.
19. Graham DY, Opekun AR, Hammoud F, et al,. Studies regarding the mechanism of false negative urea breath tests with proton pump inhibitors. Am J Gastroenterol 2003; 98: 1005-9.
20. Kuipers EJ, Uyterlinde AM, Pena AS, et al,. Increase of Helicobacter pylori-associated corpus gastritis during acid suppressive therapy: implications for long-term safety. Am J Gastroenterol 1995; 90: 1401-6.
21. Laine L, Estrada R, Trujillo M, et al,. Effect of proton-pump inhibitor therapy on diagnostic testing for Helicobacter pylori. Ann Intern Med 1998; 129: 547-50.
22. Genta RM,. Where have all the Helicobacters gone? J Clin Gastroenterol 2007; 41: 727-8.
23. Genta RM, Graham DY,. Comparison of biopsy sites for the histopathologic diagnosis of Helicobacter pylori: a topographic study of H. pylori density and distribution. Gastrointest Endosc 1994; 40: 342-5.
24. Nordenstedt H, Graham DY, Kramer JR, et al,. Helicobacter pylori-negative gastritis: prevalence and risk factors. Am J Gastroenterol 2013; 108: 65-71.
25. Genta RM, Schuler CM, Lash RH,. Helicobacter pylori-negative chronic active gastritis: a new entity or the result of widespread acid inhibition? Gastroenterology 2008; 134 (Suppl. 1): A-125.
26. Choi CE, Turner KO, Genta RM,. The prevalence of gastric preneoplastic lesions in East Asians and Hispanic in the United States parallel the incidence of gastric cancer in their corresponding ancestral countries. Gastrointest Endosc, 2014; 79 (Suppl. AB): 280-AB281.
27. Genta RM, Lew GM, Graham DY,. Changes in the gastric mucosa following eradication of Helicobacter pylori. Mod Pathol 1993; 6: 281-9.
28. Oberhuber G, Puspok A, Dejaco C, et al,. Minimal chronic inactive gastritis: indicator of pre-existing Helicobacter pylori gastritis? Pathol Res Pract 1996; 192: 1016-21.
29. Franceschi F, Genta RM, Sepulveda AR,. Gastric mucosa: long-term outcome after cure of Helicobacter pylori infection. J Gastroenterol 2002; 37 (Suppl. 13): 17-23.